Biologica Technologies showcasing Allofill™ at the annual American Society of Plastic Surgeons meeting

News provided by

Biologica Technologies

16 Oct, 2015, 09:30 ET

CARLSBAD, Calif., Oct. 16, 2015 /PRNewswire/ -- Biologica Technologies announced today that it will be exhibiting Allofill at the American Society of Plastic Surgeons (ASPS) Annual Meeting being held this week at Boston Convention and Exhibition Center, Boston, MA.  Biologica Technologies will be located in booth number 436.

Allofill is the first product of its kind; a ready to use, 'off the shelf', adipose derived injectable filler.  Allofill works with the body to provide an all-natural tissue scaffold with native growth factors, such as VEGF, aFGF and bFGF, which are important in angiogenesis and adipogenesis. Allofill retains the native extracellular matrix (ECM) components of adipose tissue and over time it will be remodeled into native soft tissue.

"At various times, autologous fat transfer or using other fillers may not be the most ideal procedure for a patient," stated President, Amit Govil.  "Allofill provides a very unique and new option for surgeons with a product that will remodel into native, host tissue and one that has more reliable results and cost savings over autologous fat transfer."

About Allofill and Biologica Technologies

Allofill can be used to fill soft-tissue defects as a non-invasive alternative to autologous fat grafting to provide cushioning and support for subcutaneous tissue. Allofill is intended for use in situations where autologous fat grafting is appropriate and should be restricted to homologous use of adipose tissue.  Allofill is currently undergoing clinical trials and will be available for sale in the near future.

Founded in 2015, Biologica Technologies is a company established to provide a variety of innovative biologic products across multiple medical specialties. Biologica's proprietary technology captures naturally occurring growth factors found within allograft tissue, providing patients and surgeons with novel biologic solutions. The company's first orthopaedic product, ProteiOS™, is a 'first of its kind' growth factor derived from minimally manipulated allogeneic bone marrow.  The company is privately-held and headquartered in Carlsbad, CA.

RELATED LINKS
http://www.biologicatechnologies.com/

SOURCE Biologica Technologies

Related Links

http://www.biologicatechnologies.com

Also from this source

Biologica Technologies® signs agreements with Premier Inc. and Academy Medical

Explore

More news releases in similar topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.